Download PDF
Semin Neurol 2020; 40(05): 515-522
DOI: 10.1055/s-0040-1713886
Review Article

Management of Orthostatic Hypotension, Postprandial Hypotension, and Supine Hypertension

Cyndya A. Shibao
1   Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
,
Italo Biaggioni
1   Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

This review provides recommendations for the treatment of neurogenic orthostatic hypotension (nOH), postprandial hypotension, and supine hypertension. It focuses on novel treatment strategies and new insights into the mechanism underlying these conditions. Our goal is to provide practical advice for clinicians on how to screen, diagnose, and treat these conditions with nonpharmacological and pharmacological approaches. For each disorder, we offered a stepwise recommendation on how to apply these new concepts to successfully ameliorate the symptoms associated with OH to prevent syncope and falls. The management of OH in patients who also have supine hypertension requires special considerations and pharmacotherapy. It is noteworthy that there are few therapeutic options for OH and only two Food and Drug Administration–approved drugs for the treatment of OH and nOH based on randomized clinical trials. We will use these studies to develop evidence-based guidelines for OH. The research is limited for postprandial hypotension and supine hypertension, and therefore the recommendations will be based on small studies, clinical expertise, and, above all, an understanding of the underlying pathophysiology.

Keywords

orthostatic hypotension - postprandial hypotension - supine hypertension - midodrine - droxidopa


Publication History

Article published online:
14 October 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 

  • References

  • 1 Gibbons CH, Schmidt P, Biaggioni I. et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 2017; 264 (08) 1567-1582
    CrossrefPubMedGoogle Scholar
  • 2 Diedrich A, Biaggioni I. Segmental orthostatic fluid shifts. Clin Auton Res 2004; 14 (03) 146-147
    CrossrefPubMedGoogle Scholar
  • 3 Norcliffe-Kaufmann L, Kaufmann H, Palma JA. , et al; Autonomic Disorders Consortium. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 2018; 83 (03) 522-531
    CrossrefPubMedGoogle Scholar
  • 4 Novak V, Novak P, Spies JM, Low PA. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke 1998; 29 (01) 104-111
    CrossrefPubMedGoogle Scholar
  • 5 Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L. et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?. Mov Disord 2015; 30 (05) 639-645
    CrossrefPubMedGoogle Scholar
  • 6 Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. CHS Collaborative Research Group.. Orthostatic hypotension in older adults. The Cardiovascular Health Study. Hypertension 1992; 19 (6, Pt 1): 508-519
    CrossrefPubMedGoogle Scholar
  • 7 Miyamoto Y, Saito Y, Kajiyama N. et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32 (01) 3-8
    CrossrefPubMedGoogle Scholar
  • 8 Shibao C, Grijalva CG, Raj SR, Biaggioni I, Griffin MR. Orthostatic hypotension-related hospitalizations in the United States. Am J Med 2007; 120 (11) 975-980
    CrossrefPubMedGoogle Scholar
  • 9 Holmgren A, Jonsson B, Levander M, Linderholm H, Sjostrand T, Strom G. Low physical working capacity in suspected heart cases due to inadequate adjustment of peripheral blood flow (vasoregulatory asthenia). Acta Med Scand 1957; 158 (06) 413-436
    CrossrefPubMedGoogle Scholar
  • 10 Shibao C, Grijalva CG, Lipsitz LA, Biaggioni I, Griffin MR. Early discontinuation of treatment in patients with orthostatic hypotension. Auton Neurosci 2013; 177 (02) 291-296
    CrossrefPubMedGoogle Scholar
  • 11 Ricci F, Fedorowski A, Radico F. et al. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J 2015; 36 (25) 1609-1617
    CrossrefPubMedGoogle Scholar
  • 12 Sarasin FP, Louis-Simonet M, Carballo D, Slama S, Junod AF, Unger PF. Prevalence of orthostatic hypotension among patients presenting with syncope in the ED. Am J Emerg Med 2002; 20 (06) 497-501
    CrossrefPubMedGoogle Scholar
  • 13 Frewen J, Savva GM, Boyle G, Finucane C, Kenny RA. Cognitive performance in orthostatic hypotension: findings from a nationally representative sample. J Am Geriatr Soc 2014; 62 (01) 117-122
    CrossrefPubMedGoogle Scholar
  • 14 Mehrabian S, Duron E, Labouree F. et al. Relationship between orthostatic hypotension and cognitive impairment in the elderly. J Neurol Sci 2010; 299 (1-2): 45-48
    CrossrefPubMedGoogle Scholar
  • 15 Poda R, Guaraldi P, Solieri L. et al. Standing worsens cognitive functions in patients with neurogenic orthostatic hypotension. Neurol Sci 2012; 33 (02) 469-473
    CrossrefPubMedGoogle Scholar
  • 16 Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A. Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology 2017; 88 (01) 17-24
    CrossrefPubMedGoogle Scholar
  • 17 Bird ST, Delaney JA, Brophy JM, Etminan M, Skeldon SC, Hartzema AG. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology. BMJ 2013; 347: f6320
    CrossrefPubMedGoogle Scholar
  • 18 Podoleanu C, Maggi R, Brignole M. et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol 2006; 48 (07) 1425-1432
    CrossrefPubMedGoogle Scholar
  • 19 Smit AA, Wieling W, Fujimura J. et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res 2004; 14 (03) 167-175
    PubMedGoogle Scholar
  • 20 Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D. A potent pressor response elicited by drinking water. Lancet 1999; 353 (9154): 723
    CrossrefPubMedGoogle Scholar
  • 21 ten Harkel AD, Baisch F, Karemaker JM. Increased orthostatic blood pressure variability after prolonged head-down tilt. Acta Physiol Scand Suppl 1992; 604: 89-99
    PubMedGoogle Scholar
  • 22 van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res 2000; 10 (01) 35-42
    CrossrefPubMedGoogle Scholar
  • 23 Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. ; Midodrine Study Group. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. JAMA 1997; 277 (13) 1046-1051
    CrossrefPubMedGoogle Scholar
  • 24 Wright RA, Kaufmann HC, Perera R. et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998; 51 (01) 120-124
    CrossrefPubMedGoogle Scholar
  • 25 Kaufmann H, Freeman R, Biaggioni I. , et al; NOH301 Investigators. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 2014; 83 (04) 328-335
    CrossrefPubMedGoogle Scholar
  • 26 Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H. ; Droxidopa 302 Investigators. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension 2015; 65 (01) 101-107
    CrossrefPubMedGoogle Scholar
  • 27 Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B). Mov Disord 2015; 30 (05) 646-654
    CrossrefPubMedGoogle Scholar
  • 28 Biaggioni I, Arthur Hewitt L, Rowse GJ, Kaufmann H. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension. BMC Neurol 2017; 17 (01) 90
    CrossrefPubMedGoogle Scholar
  • 29 McDonell KE, Preheim BA, Diedrich A. et al. Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients. J Clin Hypertens (Greenwich) 2019; 21 (09) 1308-1314
    CrossrefPubMedGoogle Scholar
  • 30 Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med 1979; 301 (02) 68-73
    CrossrefPubMedGoogle Scholar
  • 31 Campbell IW, Ewing DJ, Clarke BF. 9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes 1975; 24 (04) 381-384
    CrossrefPubMedGoogle Scholar
  • 32 Hoehn MM. Levodopa-induced postural hypotension. Treatment with fludrocortisone. Arch Neurol 1975; 32 (01) 50-51
    CrossrefPubMedGoogle Scholar
  • 33 Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 2003; 74 (09) 1294-1298
    CrossrefPubMedGoogle Scholar
  • 34 Singer W, Sandroni P, Opfer-Gehrking TL. et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 2006; 63 (04) 513-518
    CrossrefPubMedGoogle Scholar
  • 35 Shibao C, Okamoto LE, Gamboa A. et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension 2010; 56 (05) 847-851
    CrossrefPubMedGoogle Scholar
  • 36 Simpson D, Plosker GL. Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. Drugs 2004; 64 (02) 205-222
    CrossrefPubMedGoogle Scholar
  • 37 Shibao C, Raj SR, Gamboa A. et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension 2007; 50 (01) 47-53
    CrossrefPubMedGoogle Scholar
  • 38 Ramirez CE, Okamoto LE, Arnold AC. et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension 2014; 64 (06) 1235-1240
    CrossrefPubMedGoogle Scholar
  • 39 Jansen RWMM, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Int Med 1995; 122: 286-295
    PubMedGoogle Scholar
  • 40 Aronow WS, Ahn C. Postprandial hypotension in 499 elderly persons in a long-term health care facility. J Am Geriatr Soc 1994; 42 (09) 930-932
    CrossrefPubMedGoogle Scholar
  • 41 Chaudhuri KR, Ellis C, Love-Jones S. et al. Postprandial hypotension and parkinsonian state in Parkinson's disease. Mov Disord 1997; 12 (06) 877-884
    CrossrefPubMedGoogle Scholar
  • 42 Puvi-Rajasingham S, Mathias CJ. Effect of meal size on post-prandial blood pressure and on postural hypotension in primary autonomic failure. Clin Auton Res 1996; 6 (02) 111-114
    CrossrefPubMedGoogle Scholar
  • 43 Visvanathan R, Chen R, Garcia M, Horowitz M, Chapman I. The effects of drinks made from simple sugars on blood pressure in healthy older people. Br J Nutr 2005; 93 (05) 575-579
    CrossrefPubMedGoogle Scholar
  • 44 Fukushima T, Asahina M, Fujinuma Y. et al. Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy. J Neurol 2013; 260 (02) 475-483
    CrossrefPubMedGoogle Scholar
  • 45 Shibao C, Gamboa A, Diedrich A. et al. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension 2007; 50 (01) 54-61
    CrossrefPubMedGoogle Scholar
  • 46 Lyons TJ, McLoughlin JC, Shaw C, Buchanan KD. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome. Digestion 1985; 31 (2-3): 89-96
    CrossrefPubMedGoogle Scholar
  • 47 Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 2000; 355 (9205): 725-726
    CrossrefPubMedGoogle Scholar
  • 48 Garland EM, Gamboa A, Okamoto L. et al. Renal impairment of pure autonomic failure. Hypertension 2009; 54 (05) 1057-1061
    CrossrefPubMedGoogle Scholar
  • 49 Shannon JR, Jordan J, Diedrich A. et al. Sympathetically mediated hypertension in autonomic failure. Circulation 2000; 101 (23) 2710-2715
    CrossrefPubMedGoogle Scholar
  • 50 Gamboa A, Shibao C, Diedrich A. et al. Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension 2008; 51 (06) 1531-1536
    CrossrefPubMedGoogle Scholar
  • 51 Arnold AC, Okamoto LE, Gamboa A. et al. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure. Hypertension 2013; 61 (03) 701-706
    CrossrefPubMedGoogle Scholar
  • 52 Arnold AC, Okamoto LE, Gamboa A. et al. Mineralocorticoid receptor activation contributes to the supine hypertension of autonomic failure. Hypertension 2016; 67 (02) 424-429
    CrossrefPubMedGoogle Scholar
  • 53 Okamoto LE, Gamboa A, Shibao C. et al. Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension 2009; 53 (02) 363-369
    CrossrefPubMedGoogle Scholar
  • 54 Biaggioni I, Garcia F, Inagami T, Haile V. Hyporeninemic normoaldosteronism in severe autonomic failure. J Clin Endocrinol Metab 1993; 76 (03) 580-586
    PubMedGoogle Scholar
  • 55 Kario K, Ishikawa J, Hoshide S. et al. Diabetic brain damage in hypertension: role of renin-angiotensin system. Hypertension 2005; 45 (05) 887-893
    CrossrefPubMedGoogle Scholar
  • 56 Jordan J, Shannon JR, Pohar B. et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 1999; 10 (01) 35-42
    CrossrefPubMedGoogle Scholar
  • 57 Pahor M, Guralnik JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995; 43 (11) 1191-1197
    CrossrefPubMedGoogle Scholar
  • 58 Okamoto LE, Gamboa A, Shibao CA. et al. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension. Hypertension 2014; 64 (06) 1241-1247
    CrossrefPubMedGoogle Scholar